Data pp 203-208 | Cite as

Supplemental Ascorbate, Vitamin C, in the Supportive Treatment of Cancer

  • D. F. Andrews
  • A. M. Herzberg
Part of the Springer Series in Statistics book series (SSS)


A study was made of the survival times of 100 terminal cancer patients who were given supplemental ascorbate, Vitamin C, as part of their routine management and 1000 matched controls, similar patients who had received the same treatment except for the ascorbate. The object of the investigation was to determine whether supplemental ascorbate prolongs the survival times of patients with terminal human cancer.


Survival Time Matched Control Supportive Treatment Short Survival Time District General Hospital 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Cameron, E. and Pauling, L. (1976). Supplemental ascorbate in the supportive treatment of cancer: Prolongation of survival times in terminal human cancer. Proc. Nad. Acad. Sci. U.S.A. 73, 3685–3689.CrossRefGoogle Scholar

Copyright information

© Springer-Verlag New York 1985

Authors and Affiliations

  • D. F. Andrews
    • 1
  • A. M. Herzberg
    • 2
  1. 1.Department of StatisticsUniversity of TorontoTorontoCanada
  2. 2.Department of MathematicsImperial College of Science and TechnologyLondonUK

Personalised recommendations